Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 27/11/2020
SIETES contiene 93167 citas

 
 
 1 a 14 de 14 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Shlipak MG, Mathushita K, Arnlov J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT, for the CKD Prognosis Consortium. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013;369:932-43. [Ref.ID 96070]
2. Cita con resumen
Early A, Miskulin D, Lamb EJ, Levey AS, Uhlig K. Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med 2012;156:785-95. [Ref.ID 93110]
3.Tiene citas relacionadas Cita con resumen
Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghome KR, Shankar A, Smith DH, Tonelli M, Wamock DG, Wen C-P, Coresh J, Gansevoort RT, Hemmelgam BR, Levey AS, for the Chronic Kidney Disease Prognosis Consortium. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012;307:1941-51. [Ref.ID 92860]
4.Tiene citas relacionadas Cita con resumen
Pfeffer MA, Burdmann EA, Chen C-Y, Cooper ME, de Zeeuw D, Eckardt K-U, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJV, Parfrey P, Parving H-H, Remuzzi G, Singh AK, Solomon SD, Toto R, for the TREAT Investigators. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009;361:2019-32. [Ref.ID 87324]
5. Cita con resumen
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro III AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, +, Greene T, Coresh J, for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12. [Ref.ID 85873]
6.
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-47. [Ref.ID 81584]
7.Tiene citas relacionadas Cita con resumen
Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey AS, Pfeiffer E, Sano M, van Dyck CH, Thal LJ, for the Alzheimer's Disease Cooperative Study Group. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352:2379-88. [Ref.ID 74029]
8.
Rahman M, Brown CD, Coresh J, Davis BR, Eckfeldt JH, Kopyt N, Levey AS, Nwachuku C, Pressel S, Reisin E, Walworth C, for the ALLHAT Collaborative Research Group. The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease. A report from the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Arch Intern Med 2004;164:969-76. [Ref.ID 70061]
9.
Levey AS, Coresh J, Balk E, Kausz A T, Levin A, Steffes MW, Hogg RJ, Perrone R D, Lau J, Eknoyan G. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-47. [Ref.ID 66885]
10.Tiene citas relacionadas Cita con resumen
Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de Zeeuw D, Lau J, Levey AS, for the ACE Inhibition in Progressive Renal Disease Study Group. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. Ann Intern Med 2001;135:73-87. [Ref.ID 57777]
11.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, for the Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-70. [Ref.ID 43397]
12.
Levey AS, Lau J. Antilymphocyte antibodies, renal transplantation, and meta-analysis. Ann Intern Med 1998;128:863-5. [Ref.ID 38407]
13.Tiene citas relacionadas
Levey AS, Lau J, Giatras I. Angiotensin-converting enzyme inhibitors in nondiabetic renal disease. In response. Ann Intern Med 1998;128:694-5. [Ref.ID 38324]
14.Tiene citas relacionadas
Giatras I, Lau J, Levey AS, for the Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Ann Intern Med 1997;127:337-45. [Ref.ID 34325]
Seleccionar todas
 
 1 a 14 de 14